Who would be the first to get a COVID-19 vaccine?

About a dozen different vaccines are in various stages of testing worldwide, including in Britain, China and the US

Image
AP Washington
2 min read Last Updated : Jun 25 2020 | 2:52 PM IST

Who would be the first to get a COVID-19 vaccine? Probably people in the country where the first effective vaccine is developed.

About a dozen different vaccines are in various stages of testing worldwide, including in Britain, China and the US.

This week, Dr. Anthony Fauci, the top US infectious disease expert, said he is cautiously optimistic there will be a COVID-19 vaccine by the end of the year or early 2021.

Several wealthy countries have already ordered millions of doses of those experimental vaccines.

Britain and the US, for example, have invested in a vaccine candidate being developed by Oxford University and produced by AstraZeneca. If it works, UK politicians have said Britons will be vaccinated with it. The US expects to start stockpiling it this fall and also has invested in other vaccine candidates.

Groups including the vaccine alliance GAVI are also working to buy doses for poor countries and AstraZeneca has agreed to license its vaccine to India's Serum Institute for the production of 1 billion doses. The World Health Organization is drafting guidelines for the ethical distribution of COVID-19 vaccines.

How vaccines are distributed within a country will vary. Last week, U.S. officials said they were developing a tiered system for that. The system would likely prioritize groups at greatest risk of severe complications from COVID-19 and key workers.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccinehealthcare

First Published: Jun 25 2020 | 2:10 PM IST

Next Story